COMMITMENTS (Details Narrative) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
Jun. 30, 2016 |
Jun. 30, 2015 |
|
Research and development expense | $ 7,516 | $ 8,871 | $ 18,187 | $ 15,700 |
Qualified Defined Contribution Plan [Member] | ||||
Employer matching contribution | 100.00% | |||
Maximum annual contributions per employee | 19.00% | |||
Maximum annual contributions per employer | 6.00% | |||
Administrative expenses | $ 68 | $ 56 | $ 201 | $ 104 |
Research And Development Contracts [Member] | ||||
Research and development expense | $ 17,500 |
X | ||||||||||
- Definition Amount of administrative expenses incurred by a defined contribution plan. No definition available.
|
X | ||||||||||
- Definition Percentage employer matches of the employee's percentage contribution matched. No definition available.
|
X | ||||||||||
- Definition Percentage of employer's matching contributions to a defined contribution plan that vests in a given year. No definition available.
|
X | ||||||||||
- Definition Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan. No definition available.
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|